12-122208431-C-T
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001371333.1(DIABLO):c.670G>A(p.Gly224Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000459 in 1,613,946 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001371333.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DIABLO | NM_001371333.1 | c.670G>A | p.Gly224Arg | missense_variant | 6/6 | ENST00000464942.7 | NP_001358262.1 | |
B3GNT4 | NM_030765.4 | c.*1043C>T | 3_prime_UTR_variant | 3/3 | ENST00000324189.5 | NP_110392.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DIABLO | ENST00000464942.7 | c.670G>A | p.Gly224Arg | missense_variant | 6/6 | 1 | NM_001371333.1 | ENSP00000442360 | P1 | |
B3GNT4 | ENST00000324189.5 | c.*1043C>T | 3_prime_UTR_variant | 3/3 | 1 | NM_030765.4 | ENSP00000319636 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00250 AC: 380AN: 152244Hom.: 2 Cov.: 33
GnomAD3 exomes AF: 0.000608 AC: 152AN: 250108Hom.: 0 AF XY: 0.000421 AC XY: 57AN XY: 135232
GnomAD4 exome AF: 0.000247 AC: 361AN: 1461584Hom.: 0 Cov.: 31 AF XY: 0.000223 AC XY: 162AN XY: 727066
GnomAD4 genome AF: 0.00249 AC: 380AN: 152362Hom.: 2 Cov.: 33 AF XY: 0.00236 AC XY: 176AN XY: 74514
ClinVar
Submissions by phenotype
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 23, 2017 | p.Gly224Arg in exon 7 of DIABLO: This variant is not expected to have clinical s ignificance because it has been identified in 0.77% (79/10230) of African chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs150199226). - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 22, 2016 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 28, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 07, 2024 | - - |
DIABLO-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 05, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at